Franceschi D - Search Results

1

Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.

Cohen BL, Collier AL, Kelly KN, Goel N, Kesmodel SB, Yakoub D, Moller M, Avisar E, Franceschi D, Macedo FI. Cohen BL, et al. Among authors: franceschi d. Ann Surg Oncol. 2020 Jun;27(6):1830-1841. doi: 10.1245/s10434-020-08227-w. Epub 2020 Jan 27. Ann Surg Oncol. 2020. PMID: 31989360

2

Tracheobronchial injury in the setting of an esophagectomy for cancer: postoperative discovery a bad omen.

Koshenkov VP, Yakoub D, Livingstone AS, Franceschi D. Koshenkov VP, et al. Among authors: franceschi d. J Surg Oncol. 2014 Jun;109(8):804-7. doi: 10.1002/jso.23577. Epub 2014 Feb 17. J Surg Oncol. 2014. PMID: 24535950

3

Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis.

Gadde R, Tamariz L, Hanna M, Avisar E, Livingstone A, Franceschi D, Yakoub D. Gadde R, et al. Among authors: franceschi d. J Surg Oncol. 2015 Jul;112(1):38-45. doi: 10.1002/jso.23945. Epub 2015 Jun 12. J Surg Oncol. 2015. PMID: 26074130 Review.

4

Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients.

Azab B, Amundson JR, Picado O, Ripat C, Macedo FI, Franceschi D, Livingstone AS, Yakoub D. Azab B, et al. Among authors: franceschi d. Ann Surg Oncol. 2019 Mar;26(3):861-868. doi: 10.1245/s10434-018-6897-4. Epub 2018 Oct 11. Ann Surg Oncol. 2019. PMID: 30311162

5

The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.

Picado O, Dygert L, Macedo FI, Franceschi D, Sleeman D, Livingstone AS, Merchant N, Yakoub D. Picado O, et al. Among authors: franceschi d. J Surg Res. 2018 Dec;232:422-429. doi: 10.1016/j.jss.2018.06.067. Epub 2018 Jul 21. J Surg Res. 2018. PMID: 30463751

6

Utility of Radiation After Neoadjuvant Chemotherapy for Surgically Resectable Esophageal Cancer.

Macedo FI, Mesquita-Neto JW, Kelly KN, Azab B, Yakoub D, Merchant NB, Livingstone AS, Franceschi D. Macedo FI, et al. Among authors: franceschi d. Ann Surg Oncol. 2020 Mar;27(3):662-670. doi: 10.1245/s10434-019-07788-9. Epub 2019 Dec 1. Ann Surg Oncol. 2020. PMID: 31788752

7

The Effect of Hospital Volume on Outcomes of Patients with Occult Breast Cancer.

Baumrucker CC, Spring SR, Cohen BL, Millen JC, Macedo FI, Franceschi D. Baumrucker CC, et al. Among authors: franceschi d. Ann Surg Oncol. 2021 Apr;28(4):2128-2135. doi: 10.1245/s10434-020-09103-3. Epub 2020 Sep 10. Ann Surg Oncol. 2021. PMID: 32914387

8

Axillary response rates to neoadjuvant chemotherapy in breast cancer patients with advanced nodal disease.

Goel N, Yadegarynia S, Rodgers S, Kelly K, Collier A, Franceschi D, Moller M, Avisar E, Kesmodel SB. Goel N, et al. Among authors: franceschi d. J Surg Oncol. 2021 Jul;124(1):25-32. doi: 10.1002/jso.26480. Epub 2021 Apr 14. J Surg Oncol. 2021. PMID: 33852160

9

[No title available]

[No authors listed] [No authors listed] PMID: 35286530

10

Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes.

Friedman-Eldar O, Ozmen T, El Haddi SJ, Goel N, Tjendra Y, Kesmodel SB, Moller MG, Franceschi D, Layton C, Avisar E. Friedman-Eldar O, et al. Among authors: franceschi d. Ann Surg Oncol. 2022 Mar 18. doi: 10.1245/s10434-022-11473-9. Online ahead of print. Ann Surg Oncol. 2022. PMID: 35303178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters